BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29731768)

  • 1. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.
    Han XG; Mo HM; Liu XQ; Li Y; Du L; Qiao H; Fan QM; Zhao J; Zhang SH; Tang TT
    Front Genet; 2018; 9():135. PubMed ID: 29731768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
    Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
    Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.
    Han XG; Du L; Qiao H; Tu B; Wang YG; Qin A; Dai KR; Fan QM; Tang TT
    Cancer Lett; 2015 Dec; 369(2):405-15. PubMed ID: 26391645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway.
    Li Z; Xu R; Zhang X; Shen J; Chen G; Zou T; Yu X
    Exp Ther Med; 2020 Feb; 19(2):1379-1387. PubMed ID: 32010312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM4 Expression Related to Malignant Progression and Cisplatin Resistance in Osteosarcoma.
    Li Y; Gao J; Wang D; Liu Z; Zhang H
    Appl Biochem Biotechnol; 2024 Jan; 196(1):233-244. PubMed ID: 37115387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
    Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
    Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.
    Liu F; Wang K; Zhang L; Yang YL
    Oncol Lett; 2018 Oct; 16(4):5113-5121. PubMed ID: 30250579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressive role of TIMP3 in the human osteosarcoma cells.
    Tan B; Xu X; Zhang Q; Yuan Z; Dong J
    J Orthop Sci; 2022 May; 27(3):689-695. PubMed ID: 33814198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
    [No Abstract]   [Full Text] [Related]  

  • 11. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
    Li C; Cai J; Ge F; Wang G
    Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma.
    Dai H; Huang Y; Li Y; Meng G; Wang Y; Guo QN
    Carcinogenesis; 2012 Jan; 33(1):30-40. PubMed ID: 22021909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
    Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
    [No Abstract]   [Full Text] [Related]  

  • 16. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
    Zhang W; Li Q; Song C; Lao L
    Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
    Wu Z; Liu J; Hu S; Zhu Y; Li S
    Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDRG2 alleviates photoreceptor apoptosis by regulating the STAT3/TIMP3/MMP pathway in mice with retinal degenerative disease.
    Chen T; Xiong Y; Deng C; Hu C; Li M; Quan R; Yu X
    FEBS J; 2024 Mar; 291(5):986-1007. PubMed ID: 38037211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.